A new study conducted at the VIB-KU Leuven Center for Cancer Biology in Belgium has labeled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer. By examining macrophages at the sites of metastases, the scientists have now described the ‘anti-metastatic surveillance’ role of Caveolin-1 for the first time.
Welcome to the Leuven Cancer Institute, the LKI. The LKI unites doctors, caretakers and researches of University Hospitals Leuven and the KU Leuven in their fight against cancer. The LKI strives to coordinate research, therapy and care in the best way possible. We invest in targeted projects and incorporate innovative technologies, spanning several domains of cancer.
Together we can achieve progress faster and play a leading role in the battle against cancer. Every ally, each partner makes us stronger. Thank you for your support.
Prof. dr. Michel Delforge, chairman of the LKI